Endothelial nitric oxide synthase gene polymorphisms associated with susceptibility to high altitude pulmonary edema in Chinese railway construction workers at Qinghai-Tibet over 4 500 meters above sea Level

doi:10.1016/S1001-9294(11)60005-9

Abstract

Abstract: Objective To examine whether the polymorphisms of endothelial nitric oxide synthase (eNOS) gene are associated with the susceptibility to high altitude pulmonary edema (HAPE) in Chinese railway construction workers at Qinghai-Tibet where the altitude is over 4 500 m above sea level. Methods A case-control study was conducted including 149 HAPE patients in the construction workers and 160 healthy controls randomly recruited from their co-workers, matching the patients in ethnicity, age, sex, lifestyle, and working conditions. Three polymorphisms of eNOS gene, T-786C in promoter, 894G/T in exon 7, and 27bp variable number tandem repeat (VNTR) in intron 4, were genotyped using polymerase chain reaction (PCR) and confirmed with DNA sequencing. Results The frequencies of 894T allele and heterozygous G/T of the 894G/T variant were significantly higher in HAPE patients group than in the control group (P=0.0028 and P=0.0047, respectively). However, the frequencies of the T-786C in promoter and the 27bp VNTR in intron 4 were not significantly different between the two groups. Haplotypic analysis revealed that the frequencies of two haplotypes (H3,T-T-b, b indicates 5 repeats of 27 bp VNTR; H6, C-G-a, a indicates 4 repeats of 27 bp VNTR) were significantly higher in HAPE patients (both P＜0.0001). On the contrary, the frequencies of H1 (T-G-b) and H2 (T-G-a) were lower in HAPE patients than in healthy controls (both P＜0.001). Conclusions Two haplotypes (T-T-b and C-G-a) may be strongly associated with susceptibility to HAPE. Compared with the individual alleles of eNOS gene, the interaction of multiple genetic markers within a haplotype may be a major determinant for the susceptibility to HAPE.

Key words: high altitude pulmonary edema, nitric oxide synthase;gene polymorphism, haplotype

Yu-jing Sun, Ming-wu Fang, Wen-quan Niu, Guang-ping Li, Jing-liang Liu, Shou-quan Ding, Ying Xu, Guo-shu Yu, Jian-qun Dong, Yun-jun Pan,Wei-ya Dong, Tian Wang, Jing-wen Cao, Xiao-bo Li, Zhong-xiang Wang, Guang-xue Yu, Hui-cheng Sun, Zhong-hou Jia, Jun Liu, Xiao-ming Wang, Qin Si, Qi-xia Wu, Wen-yu Zhou, Tong-chun Zhu and Chang-chun Qiu. Endothelial nitric oxide synthase gene polymorphisms associated with susceptibility to high altitude pulmonary edema in Chinese railway construction workers at Qinghai-Tibet over 4 500 meters above sea Level[J].Chinese Medical Sciences Journal, 2010, 25(4): 215-222.

References 29

1.	Hackett PH, Roach RC. High-altitude illness. N Engl J Med 2001; 345:107-14.
2.	Mortimer H, Patel S, Peacock AJ. The genetic basis of high-altitude pulmonary oedema. Pharmacol Ther 2004; 101:183-92
3.	Hotta J, Hanaoka M, Droma Y, et al. Polymorphisms of renin-angiotensin system genes with high-altitude pul-monary edema in Japanese subjects. Chest 2004; 126: 825-30.
4.	Qi Y, Niu W, Zhu T, et al. Synergistic effect of the genetic polymorphisms of the renin-angiotensin-aldosterone sys- tem on high-altitude pulmonary edema: a study from Qinghai-Tibet altitude. Eur J Epidemiol 2008; 23:143-52.
5.	Saxena S, Kumar R, Madan T, et al. Association of poly-morphisms in pulmonary surfactant protein A1 and A2 genes with high-altitude pulmonary edema. Chest 2005; 128:1611-9.
6.	Qi Y, Niu WQ, Zhu TC, et al. Genetic interaction of Hsp70 family genes polymorphisms with high-altitude pulmonary edema among Chinese railway constructor at altitudes exceeding 4000 meters. Clin Chim Acta 2009; 405:17-22.
7.	Stobdan T, Kumar R, Mohammad G, et al. Probable role of beta2-adrenergic receptor gene haplotype in high-altitude pulmonary oedema. Respirology 2010; 15:651-8.
8.	Anand IS, Prasad BA, Chugh SS, et al. Effects of inhaled nitric oxide and oxygen in high-altitude pulmonary edema. Circulation 1998; 98:2441-5.
9.	Ahsan A, Mohd G, Norboo T, et al. Heterozygotes of NOS3 polymorphisms contribute to reduced nitrogen oxides in high-altitude pulmonary edema. Chest 2006; 130:1511-9.
10	Palmer RM, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987; 327:524-6.
11	Palmer LA, Semenza GL, Stoler MH, et al. Hypoxia induces type II NOS gene expression in pulmonary artery endo-thelial cells via HIF-1. Am J Physiol 1998; 274:L212-9.
12	Moncada S, Palmer RM, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991; 43:109-42.
13	Chartrain NA, Geller DA, Koty PP, et al. Molecular cloning, structure, and chromosomal localization of the human inducible nitric oxide synthase gene. J Biol Chem 1994; 269:6765-72.
14	Grasemann H, Yandava CN, Storm van’s Gravesande K, et al. A neuronal NO synthase (NOS1) gene polymorphism is associated with asthma. Biochem Biophys Res Commun 2000; 272:391-4.
15	Marsden PA, Heng HH, Scherer SW, et al. Structure and chromosomal localization of the human constitutive en-dothelial nitric oxide synthase gene. J Biol Chem 1993; 268:17478-88.
16	Droma Y, Hanaoka M, Ota M, et al. Positive association of the endothelial nitric oxide synthase gene polymorphisms with high-altitude pulmonary edema. Circulation 2002; 106:826-30.
17	Weiss J, Haefeli WE, Gasse C, et al. Lack of evidence for association of high altitude pulmonary edema and poly-morphisms of the NO pathway. High Alt Med Biol 2003; 4:355-66.
18	Lorenzo VF, Yang Y, Simonson TS, et al. Genetic adapta-tion to extreme hypoxia: Study of high-altitude pulmonary edema in a three-generation Han Chinese family. Blood Cells Mol Dis 2009; 43:221-5.
19	Dhillom SS, Mahadevan K, Bandi V, et al. Neutrophils, nitric oxide and microvascular permeability in severe sepsis. Chest 2005; 128:1706-12.
20	Yoshimura M, Yasue H, Nakayama M, et al. Genetic risk factors for coronary artery spasm: significance of endo-thelial nitric oxide synthase gene t-786-->c and missense glu298asp variants. J Investig Med 2000; 48:367-74.
21	Lamblin N, Cuilleret FJ, Helbecque N, et al. A common variant of endothelial nitric oxide synthase (Glu298Asp) is associated with collateral development in patients with chronic coronary occlusions. BMC Cardiovasc Disord 2005; 5:27.
22	Ahsan A, Charu R, Pasha MA, et al. eNOS allelic variants at the same locus associate with HAPE and adaptation. Thorax 2004; 59:1000-2.
23	Hingorani AD, Liang CF, Fatibene J, et al. A common variant of the endothelial nitric oxide synthase (Glu298→Asp) is a major risk factor for coronary artery disease in the UK. Circulation 1999; 100:1515-20.
24	Tanus-Santos JE, Desai M, Flockhart DA. Effects of eth-nicity on the distribution of clinically relevant endothelial nitric oxide variants. Pharmacogenetics 2001; 11:719-25.
25	Hoffmann IS, Tavares-Mordwinkin R, Castejon AM, et al. Endothelial nitric oxide synthase polymorphism, nitric oxide production, salt sensitivity and cardiovascular risk factors in Hispanics. J Hum Hypertens 2005; 19:233-40.
26	Cox NJ, Bell GI. Disease associations. Chance, artifact, or susceptibility genes? Diabetes 1989; 38:947-50.
27	Nagassaki S, Metzger IF, Souza-Costa DC, et al. eNOS genotype is without effect on circulating nitrite/nitrate level in healthy male population. Thromb Res 2005; 115: 375-9.
28	Crawford DC, Nickerson DA. Definition and clinical im-portance of haplotypes. Annu Rev Med 2005; 56:303-20.
29	Johnson GC, Esposito L, Barratt BJ, et al. Haplotype tag-ging for the identification of common disease genes. Nat Genet 2001; 29:233-7

Early edition

Current issue

Archive

Specialties & Topics

Author center

Reviewer center